Fred E. Cohen

Fred E. Cohen is a declared insider at 7 companies (board member); the most frequent names are CareDx, Inc., Intellia Therapeutics, Inc. and Five Prime Therapeutics Inc. Between 1 January 2016 and 12 June 2026, the trades on record add up to 29 filings.

Purchases make up the whole of the open-market record (1 purchase, €1.2M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 23 share grants and 4 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

Most recently, on 16 June 2026, the filings show a share grant in CareDx, Inc. The last insider purchase was made public on 7 January 2026, 284 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.